Table 1. Baseline demographic and clinical characteristics of the study population.
| Baseline characteristics | Overall | HBeAg positive (N = 19) | HBeAg negative (N = 11) | p-valuea | |||
| n | Value | n | Value | n | Value | ||
| Age (year) [median (IQR)] | 30 | 31 (27–34) | 19 | 29 (27–33) | 11 | 33 (27–35) | 0.59 |
| Female [n (%)] | 30 | 24 (80) | 19 | 17 (89) | 11 | 7 (64) | 0.16 |
| Treatment-experienced [n (%)] | 30 | 12 (40) | 19 | 7 (37) | 11 | 5 (45) | 0.71 |
| CD4+ T-cell count (x106/L) [median (IQR)] | 30 | 100 (38–178) | 19 | 110 (38–188) | 11 | 48 (33–178) | 0.78 |
| HIV RNA (log10copies/mL) [median (IQR)] | 30 | 4.47 (4.09–5.27) | 19 | 4.46 (4.06–5.25) | 11 | 5.25 (4.25–5.50) | 0.29 |
| Alanine transaminase (IU/L) [median (IQR)] | 30 | 30 (20–39) | 19 | 27 (17–36) | 11 | 44 (21–121) | 0.06 |
| HBV DNA (log10IU/mL) [median (IQR)] | 30 | 7.35 (5.55–8.07) | 19 | 7.92 (7.34–8.31) | 11 | 3.76 (3.28–6.67) | <0.001 |
| HBV Genotype B : C [n (%)] | 30 | 5∶25 (17∶83) | 19 | 4∶15 (21∶79) | 11 | 1∶10 (9∶91) | 0.63 |
a
Fisher’s exact test or Wilcoxon rank-sum test were used.